Search Results

Displaying Results 3051-3075 of 28065 "'FORM'"

Aug 03, 2026, 08:30 ET SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum

factors and risks identified from time to time in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which

More news about: SenesTech, Inc.


Aug 03, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.8 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion

statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings

More news about: Bitmine Immersion Technologies, Inc.


Aug 03, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.8 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion

statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings

More news about: Bitmine Immersion Technologies, Inc.


Aug 03, 2026, 08:15 ET CACI Names Marcie Small Executive Vice President and Chief Human Resources Officer

cause actual results to differ materially from those anticipated include, but are not limited to, the risk factors set forth in CACI's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, and other such filings that CACI makes with the Securities and Exchange Commission from time to time.

More news about: CACI International Inc


Aug 03, 2026, 08:15 ET AFSP Illinois Launches 2026 Out of the Darkness Community Walks to Raise Funds and Awareness for Suicide Prevention

raise funds, and build supportive networks:Register: Sign up as an individual walker to show your solidarity.Form a Team: Gather friends, family, or coworkers to walk together.Donate: Individuals unable to attend in person can still make a difference

More news about: American Foundation for Suicide Prevention


Aug 03, 2026, 08:15 ET AFSP Illinois Launches 2026 Out of the Darkness Community Walks to Raise Funds and Awareness for Suicide Prevention

raise funds, and build supportive networks:Register: Sign up as an individual walker to show your solidarity.Form a Team: Gather friends, family, or coworkers to walk together.Donate: Individuals unable to attend in person can still make a difference

More news about: American Foundation for Suicide Prevention


Aug 03, 2026, 08:00 ET Triquetra Health Launches BioActive Vitamin B1™--First Complete B1 Activation System with 600mg Research-Matched Dose and Full Cofactor Support

Fat-Soluble Form That Delivers 5-11× More Usable B1 Now Available on Amazon, Combining Clinical-Strength Benfotiamine with the Cofactors Most High-Dose Products OmitAUSTIN, Texas, Aug. 3, 2026 /PRNewswire/ -- Triquetra

More news about: Triquetra Health LLC


Aug 03, 2026, 08:00 ET Levi & Korsinsky LLP and Wohl & Fruchter LLP Announce Pendency and Proposed Settlement of Class Action Affecting Preferred Stockholders of Cedar Realty Trust, Inc.

Settlement Fund (as defined in the Stipulation). A full explanation of your legal rights in connection the Action and the Settlement is set forth in the long-form notice ("Notice") available on the Settlement Website at www.CedarPreferredSettlement.com.

More news about: Levi & Korsinsky, LLP and Wohl & Fruchter LLP


Aug 03, 2026, 08:00 ET BorgWarner Secures Major Extension of Multiple High-Volume Inverter Programs with Major European OEM

file with the Securities and Exchange Commission, including in Item 1A, "Risk Factors" in our most recently-filed Annual Report on Form 10-K and/or Quarterly Report on Form 10-Q. We do not undertake any obligation to update or announce publicly any updates to or revisions to any of the forward-looking

More news about: BorgWarner


Aug 03, 2026, 08:00 ET Yellow.ai, a Global Leader in Enterprise Agentic AI, to Go Public via $550 Million Merger with Bluerock Acquisition Corp. (Nasdaq: BLRK)

the Business Combination, including a copy of the BCA, will be provided in Bluerock's Current Report on Form 8-K. An investor deck will be filed together with Yellow.ai's registration statement on Form S-4, which will include a document that serves as a proxy statement of Bluerock, referred to as a proxy

More news about: Yellow.ai


Aug 03, 2026, 08:00 ET Arbe to Present at Canaccord Genuity's 46th Annual Growth Conference

Statements," "Item 3. Key Information - D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" and in the Company's Annual Report on Form 20-F for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission (the "SEC") on March 27, 2026, as well as other

More news about: Arbe


Aug 03, 2026, 08:00 ET Lipocine Appoints Michael J. Grissinger to Board of Directors

manufacturing and commercialization of Lipocine's products, and other risks detailed in Lipocine's filings with the SEC, including, without limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at 

More news about: Lipocine Inc.


Aug 03, 2026, 08:00 ET POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure

services, along with pharmaceutical real-world study ("RWS") and real-world data ("RWD") services. Together, these synergized business lines are intended to form an integrated healthcare ecosystem to support operating stability while creating additional opportunities for recurring revenue, institutional commercialization

More news about: POMDOCTOR LIMITED


Aug 03, 2026, 08:00 ET FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection

obtains approval, it will be successfully distributed and marketed; and other risks and uncertainties described in the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on May 12, 2026, and in the Company's subsequent filings

More news about: Acurx Pharmaceuticals, Inc.


Aug 03, 2026, 07:50 ET EVE AIR MOBILITY ACHIEVES FIRST TRANSITION FLIGHT MILESTONE, ADVANCING EVTOL PROGRAM TOWARD WING-BORNE FLIGHT

Operations of the company's most recent Annual Report on Form 10-K, Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors of the company's most recent Quarterly Report on Form 10-Q, and other risks and uncertainties listed from

More news about: Eve Air Mobility


Aug 03, 2026, 07:45 ET Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking

More news about: Eli Lilly and Company


Aug 03, 2026, 07:30 ET Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology

and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Keenova's most recent Annual Reports on Form 10-K, and other filings and furnishings with the Securities and Exchange Commission (SEC), all of which are available from the SEC's website (

More news about: Keenova Therapeutics


Aug 03, 2026, 07:17 ET Natural Grocers® Celebrates 71 Years With Beach-Worthy Savings, Freebies and a Chance to Win a Toyota® RAV4 Hybrid, Aug. 13-15, 2026

partners. More than 4,200 prizes will be awarded throughout the sweepstakes. Customers can enter in-store by completing an Anniversary Sweepstakes entry form available at all Natural Grocers locations from Aug. 13–15.[vii]In addition, customers can win a $500 Natural Grocers gift card by

More news about: Natural Grocers by Vitamin Cottage, Inc.


Aug 03, 2026, 07:00 ET Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

TherapyREQORSA (quaratusugene ozeplasmid) consists of a plasmid containing the TUSC2 gene encapsulated in non-viral lipid-based nanoparticles in a lipoplex form (the Company's Oncoprex® Delivery System), which has a positive charge. REQORSA is injected intravenously and specifically targets cancer

More news about: Genprex, Inc.


Aug 03, 2026, 07:00 ET Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus

for service for the additional capacity and upon energization of that capacity. "This is 'scale with discipline' in contract form," said David Halabu, Chief Executive Officer of Z Squared. "Eighty percent of the total consideration is earned only as the Union County Campus

More news about: Z Squared Inc.


Aug 03, 2026, 07:00 ET Compugen Reports Second Quarter 2026 Results

products of commercial value. These risks and other risks are more fully discussed in the "Risk Factors" section of Compugen's most recent Annual Report on Form 20-F as filed with the Securities and Exchange Commission (SEC) as well as other documents that may be subsequently filed by Compugen from time to time

More news about: Compugen Ltd.


Aug 03, 2026, 07:00 ET Marriott International Reports Second Quarter 2026 Results

the risk factors that we describe in our U.S. Securities and Exchange Commission filings, including our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. Any of these factors could cause actual results to differ materially from the expectations we express or imply in this press release.ABOUT

More news about: Marriott International, Inc.


Aug 03, 2026, 06:40 ET Southern Company announces offerings of $650 million in aggregate principal amount of Convertible Senior Notes due December 15, 2027 and $1.5 billion in aggregate principal amount of Convertible Senior Notes due September 15, 2029

results will be realized. The following factors, in addition to those discussed in Southern Company's Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and subsequent securities filings, could cause actual

More news about: Southern Company


Aug 03, 2026, 06:30 ET AZZ Inc. Announces the Appointment of Rhonda Davenport as Chief Human Resources Officer

provided additional information regarding risks associated with the business, including in Part I, Item 1A. Risk Factors, in AZZ's Annual Report on Form 10-K for the fiscal year ended February 28, 2026, and other filings with the SEC, available for viewing on AZZ's website at

More news about: AZZ, Inc.


Aug 03, 2026, 06:30 ET American Bitcoin Reports Second Quarter 2026 Results

Company. Additional factors that could cause results to differ materially from those described above can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in other documents filed by the Company from time to time with the SEC.Adjusted EBITDAIn

More news about: American Bitcoin Corp.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.